David Ristenpart

With a strong background in manufacturing and marketing in Southern California, and has been a co-founder of FuturaGene, Inc. with Dr. Bruno Ruggiero in 2001, David has remained in either an active management role or as a contributing “angel investor” in virtually every commercial venture involving, among others, the Osmotin protein, since its valuation was first conceptualized.

As CFO of 9th Dimension Biotech Inc., David is well-positioned to direct the production and commercialization aspects of 9D’s product pipeline.

David co-founded 9D with the goal of advancing key technologies to offer tangible solutions to major human health and agricultural issues.